Telemedicine Specialty Support Promotes Hepatitis C Treatment by Primary Care Providers in the Department of Veterans Affairs

American Journal of Medicine

Volumn 130, Issue 4, 2017, Pages 432-438.e3

  Beste, Lauren A ^a,b   Glorioso, Thomas J ^c,d   Ho, P Michael ^c,e   Au, David H ^a,b   Kirsh, Susan R ^f,g,h   Todd Stenberg, Jeffrey ^a   Chang, Michael F ^i,j   Dominitz, Jason A ^a,b   Barón, Anna E ^b   Ross, David ^k,l  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c VA Eastern Colorado Health Care System   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^f LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^g CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁱ PORTLAND VA MEDICAL CENTER   (United States)

^j OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^k DEPARTMENT OF VETERANS AFFAIRS   (United States)

^l GEORGE WASHINGTON UNIVERSITY   (United States)

more..

Author keywords

Antiviral therapy; Project ECHO; Telemedicine

Indexed keywords

ANTIVIRUS AGENT;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; CHRONIC HEPATITIS C; CLINICAL OUTCOME; FEMALE; GENERAL PRACTITIONER; GOVERNMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SUSTAINED VIROLOGIC RESPONSE; TELECONFERENCE; TELEMEDICINE; HEPATITIS C, CHRONIC; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PRIMARY HEALTH CARE; PROCEDURES; PROGRAM EVALUATION; TREATMENT OUTCOME; UNITED STATES;

ANTIVIRAL AGENTS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PROGRAM EVALUATION; TELEMEDICINE; TREATMENT OUTCOME; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 85009812099     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2016.11.019     Document Type: Article

References (28)

1. 1 Dominitz, J.A., Boyko, E.J., Koepsell, T.D., et al. Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology 41 (2005), 88–96.
2. 2 Beste, L.A., Ioannou, G.N., Prevalence and treatment of chronic hepatitis C virus infection in the US Department of Veterans Affairs. Epidemiol Rev 37 (2015), 131–143.
3. 3 Beste, L.A., Leipertz, S.L., Green, P.K., Dominitz, J.A., Ross, D., Ioannou, G.N., Trends in the burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US Veterans from 2001-2013. Gastroenterology 149 (2015), 1471–1482.e5.
4. 4 Davis, G.L., Albright, J.E., Cook, S.F., Rosenberg, D.M., Projecting future complications of chronic hepatitis C in the United States. Liver Transpl 9 (2003), 331–338.
5. 5 Arora, S., Kalishman, S., Thornton, K., et al. Expanding access to hepatitis C virus treatment–Extension for Community Healthcare Outcomes (ECHO) project: disruptive innovation in specialty care. Hepatology 52 (2010), 1124–1133.
6. 6 Buzza, C., Ono, S.S., Turvey, C., et al. Distance is relative: unpacking a principal barrier in rural healthcare. J Gen Intern Med 26:Suppl 2 (2011), 648–654.
7. 7 Tonelli, M., Klarenbach, S., Rose, C., Wiebe, N., Gill, J., Access to kidney transplantation among remote- and rural-dwelling patients with kidney failure in the United States. JAMA 301 (2009), 1681–1690.
8. 8 Stitzenberg, K.B., Sigurdson, E.R., Egleston, B.L., Starkey, R.B., Meropol, N.J., Centralization of cancer surgery: implications for patient access to optimal care. J Clin Oncol 27 (2009), 4671–4678.
9. 9 Goldberg, D.S., French, B., Forde, K.A., et al. Association of distance from a transplant center with access to waitlist placement, receipt of liver transplantation, and survival among US veterans. JAMA 311 (2014), 1234–1243.
10. 10 Gregory, P.M., Malka, E.S., Kostis, J.B., Wilson, A.C., Arora, J.K., Rhoads, G.G., Impact of geographic proximity to cardiac revascularization services on service utilization. Med Care 38 (2000), 45–57.
11. 11 West, A.N., Lee, R.E., Shambaugh-Miller, M.D., et al. Defining “rural” for veterans' health care planning. J Rural Health 26 (2010), 301–309.
12. 12 Arora, S., Thornton, K., Murata, G., et al. Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med 364 (2011), 2199–2207.
13. 13 Kirsh, S., Su, G.L., Sales, A., Jain, R., Access to outpatient specialty care: solutions from an integrated health care system. Am J Med Qual 30 (2015), 88–90.
14. 14 Kirsh, S.R., Ho, P.M., Aron, D.C., Providing specialty consultant expertise to primary care: an expanding spectrum of modalities. Mayo Clin Proc 89 (2014), 1416–1426.
15. 15 Backus, L.I., Gavrilov, S., Loomis, T.P., et al. Clinical case registries: simultaneous local and national disease registries for population quality management. J Am Med Inform Assoc 16 (2009), 775–783.
16. 16 Corporate Data Warehouse (CDW). US Department of Veterans Affairs. Available at: http://www.hsrd.research.va.gov/for_researchers/vinci/cdw.cfm Accessed February 2, 2016.
17. 17 Vallet-Pichard, A., Mallet, V., Nalpas, B., et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology 46 (2007), 32–36.
18. 18 Kamath, P.S., Wiesner, R.H., Malinchoc, M., et al. A model to predict survival in patients with end-stage liver disease. Hepatology 33 (2001), 464–470.
19. 19 Miller, D.R., Safford, M.M., Pogach, L.M., Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data. Diabetes Care 27:Suppl 2 (2004), B10–B21.
20. 20 Kramer, J.R., Davila, J.A., Miller, E.D., Richardson, P., Giordano, T.P., El-Serag, H.B., The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases. Aliment Pharmacol Ther 27 (2008), 274–282.
21. 21 Dobscha, S.K., Morasco, B.J., Duckart, J.P., Macey, T., Deyo, R.A., Correlates of prescription opioid initiation and long-term opioid use in veterans with persistent pain. Clin J Pain 29 (2013), 102–108.
22. 22 Martin, B.C., Fan, M.Y., Edlund, M.J., Devries, A., Braden, J.B., Sullivan, M.D., Long-term chronic opioid therapy discontinuation rates from the TROUP study. J Gen Intern Med 26 (2011), 1450–1457.
23. 23 Deyo, R.A., Cherkin, D.C., Ciol, M.A., Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45 (1992), 613–619.
24. 24 Viral Hepatitis for Health Care Providers. US Department of Veterans Affairs. Available at: http://www.hepatitis.va.gov/provider/index.asp Accessed September 26, 2016.
25. 25 Zeuzem, S., Heathcote, E.J., Shiffman, M.L., et al. Twelve weeks of follow-up is sufficient for the determination of sustained virologic response in patients treated with interferon alpha for chronic hepatitis C. J Hepatol 39 (2003), 106–111.
26. 26 Yelland, L.N., Salter, A.B., Ryan, P., Performance of the modified Poisson regression approach for estimating relative risks from clustered prospective data. Am J Epidemiol 174 (2011), 984–992.
27. 27 Zickmund, S., Hillis, S.L., Barnett, M.J., Ippolito, L., LaBrecque, D.R., Hepatitis C virus-infected patients report communication problems with physicians. Hepatology 39 (2004), 999–1007.
28. 28 Zhou, C., Crawford, A., Serhal, E., Kurdyak, P., Sockalingam, S., The impact of project ECHO on participant and patient outcomes: a systematic review. Acad Med 91 (2016), 1439–1461.